{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:39:31Z","timestamp":1787063971521,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to investigate the prevalence and viral reactivations of clinical interest in the immunocompromised patient with particular focus on hematologic and solid organ transplant recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Molecular screening data of CMV, EBV, JCV and BKV from 2011 to 2023 were analyzed. This extensive time span allowed the access to more than 100,000 samples from over 20,000 patients treated at Policlinico Umberto I. It was possible to temporally investigate patient attendance patterns, average age distribution, seasonality of infections, and positivity rates of the analyzed viruses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 2019 and 2022 a significant reduction in organ transplants performed and in the positive molecular detection of EBV, JCV and BKV was observed. Additionally, there has been a noteworthy decrease in CMV reactivations, with a reduction of up to 50% starting in 2019. A remarkable reduction of 39% in the rate of CMV viral reactivation has been also achieved in SOT between 2016 and 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The years following 2019 were profoundly impacted by the COVID-19 pandemic era. This period resulted in a substantial reduction in healthcare services and hospital visits. Furthermore, the introduction of the drug Letermovir in Italy in 2019 demonstrated remarkable efficacy, evidenced by a reduction in CMV reactivations. Additionally, the adoption of a novel clinical approach centered on personalized therapy facilitated improved management of immunocompromised patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10096-024-04812-z","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T08:02:34Z","timestamp":1711094554000},"page":"979-989","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular monitoring of viral infections in immunocompromised patients in a large university hospital in Italy: reflections after thirteen years of real-life activity"],"prefix":"10.1007","volume":"43","author":[{"given":"Lilia","family":"Cinti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-3654","authenticated-orcid":false,"given":"Piergiorgio","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Paola","family":"Iori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Augurusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Girmenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"4812_CR1","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1056\/NEJMra064928","volume":"20","author":"JA Fishman","year":"2007","unstructured":"Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 20:357:2601\u20132614. https:\/\/doi.org\/10.1056\/NEJMra064928","journal-title":"N Engl J Med"},{"key":"4812_CR2","doi-asserted-by":"publisher","unstructured":"Nowalk A, Green M (2016) Epstein-Barr Virus. https:\/\/doi.org\/10.1128\/microbiolspec.DMIH2-0011-2015. Microbiol Spectr 4","DOI":"10.1128\/microbiolspec.DMIH2-0011-2015"},{"key":"4812_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ajt.12006","volume":"3","author":"CN Kotton","year":"2013","unstructured":"Kotton CN (2013) CMV: Prevention, diagnosis and therapy. Am J Transpl 3:24\u201340. https:\/\/doi.org\/10.1111\/ajt.12006","journal-title":"Am J Transpl"},{"key":"4812_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41409-019-0548-7","volume":"55","author":"R Al Hamed","year":"2020","unstructured":"Al Hamed R, Bazarbachi AH, Mohty M (2020) Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities. Bone Marrow Transpl 55:25\u201339. https:\/\/doi.org\/10.1038\/s41409-019-0548-7","journal-title":"Bone Marrow Transpl"},{"key":"4812_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/ana.26198","volume":"90","author":"R Bernard-Valnet","year":"2021","unstructured":"Bernard-Valnet R, Koralnik IJ, Du Pasquier R (2021) Advances in treatment of progressive multifocal leukoencephalopathy. Ann Neurol 90:865\u2013873. https:\/\/doi.org\/10.1002\/ana.26198","journal-title":"Ann Neurol"},{"key":"4812_CR6","doi-asserted-by":"publisher","first-page":"e2044","DOI":"10.1002\/rmv.2044","volume":"29","author":"S Chong","year":"2019","unstructured":"Chong S, Antoni M, Macdonald A, Reeves M, Harber M, Magee CN (2019) BK virus: current understanding of pathogenicity and clinical disease in transplantation. Rev Med Virol 29:e2044. https:\/\/doi.org\/10.1002\/rmv.2044","journal-title":"Rev Med Virol"},{"key":"4812_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1089\/jir.2020.0210","volume":"40","author":"BM Liu","year":"2020","unstructured":"Liu BM, Hill HR (2020) Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: a review. J Interferon Cytokine Res 40:549\u2013554. https:\/\/doi.org\/10.1089\/jir.2020.0210","journal-title":"J Interferon Cytokine Res"},{"key":"4812_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3390\/v15071449","volume":"27","author":"FJ Candel","year":"2023","unstructured":"Candel FJ, Barreiro P, Salavert M, Cabello A, Fern\u00e1ndez-Ruiz M, P\u00e9rez-Segura P et al (2023) Expert consensus: main risk factors for poor prognosis in COVID-19 and the implications for targeted measures against SARS-CoV-2. Viruses 27:15:1449. https:\/\/doi.org\/10.3390\/v15071449","journal-title":"Viruses"},{"key":"4812_CR9","doi-asserted-by":"publisher","unstructured":"Ljungman P, de la Camara R, Robin C, Crocchiolo R, Einsele H, Hill JA et al (2019) Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 1;19:e260\u201372. https:\/\/doi.org\/10.1016\/S1473-3099(19)30107-0","DOI":"10.1016\/S1473-3099(19)30107-0"},{"key":"4812_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.transproceed.2017.02.019","volume":"49","author":"R Pretagostini","year":"2017","unstructured":"Pretagostini R, Poli L, Lai Q, Russo G, Nudo F, Garofalo M et al (2017) Pre-emptive therapy for the treatment of Cytomegalovirus after kidney transplantation. Transpl Proc 49:638\u2013641. https:\/\/doi.org\/10.1016\/j.transproceed.2017.02.019","journal-title":"Transpl Proc"},{"key":"4812_CR11","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1086\/374739","volume":"15187","author":"PD Ling","year":"2003","unstructured":"Ling PD, Lednicky JA, Keitel WA, Poston DG, White ZS, Peng R et al (2003) The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: a 14-month longitudinal study. J Infect Dis 15187:1571\u20131578. https:\/\/doi.org\/10.1086\/374739","journal-title":"J Infect Dis"},{"key":"4812_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.beha.2011.06.003","volume":"24","author":"S Fuji","year":"2011","unstructured":"Fuji S, Kapp M, Grigoleit GU, Einsele H (2011) Adoptive immunotherapy with virus-specific T cells. Best Pract Res Clin Haematol 24:413\u2013419. https:\/\/doi.org\/10.1016\/j.beha.2011.06.003","journal-title":"Best Pract Res Clin Haematol"},{"key":"4812_CR13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/ajt.16449","volume":"21","author":"L Danziger-Isakov","year":"2021","unstructured":"Danziger-Isakov L, Blumberg EA, Manuel O, Sester M (2021) Impact of COVID-19 in solid organ transplant recipients. Am J Transpl 21:925\u2013937. https:\/\/doi.org\/10.1111\/ajt.16449","journal-title":"Am J Transpl"},{"key":"4812_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5114\/ceji.2014.45953","volume":"39","author":"A Szczawi\u0144ska-Pop\u0142onyk","year":"2014","unstructured":"Szczawi\u0144ska-Pop\u0142onyk A, Jo\u0144czyk-Potoczna K, Ossowska L, Br\u0119borowicz A, Bartkowska-\u015aniatkowska A, Wachowiak J (2014) Cytomegalovirus pneumonia as the first manifestation of severe combined immunodeficiency. Cent Eur J Immunol 39:392\u2013395. https:\/\/doi.org\/10.5114\/ceji.2014.45953","journal-title":"Cent Eur J Immunol"},{"key":"4812_CR15","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/ppul.25582","volume":"56","author":"G Di Mattia","year":"2021","unstructured":"Di Mattia G, Nenna R, Mancino E, Rizzo V, Pierangeli A, Villani A et al (2021) During the COVID-19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol 56:3106\u20133109. https:\/\/doi.org\/10.1002\/ppul.25582","journal-title":"Pediatr Pulmonol"},{"key":"4812_CR16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.15585\/mmwr.mm6937a6","volume":"18","author":"SJ Olsen","year":"2020","unstructured":"Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF et al (2020) Decreased influenza activity during the COVID-19 pandemic - United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep 18:69:1305\u20131309. https:\/\/doi.org\/10.15585\/mmwr.mm6937a6","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4812_CR17","doi-asserted-by":"publisher","first-page":"740079","DOI":"10.3389\/fonc.2021.740079","volume":"11","author":"M Martino","year":"2021","unstructured":"Martino M, Pitino A, Gori M, Bruno B, Crescimanno A, Federico V et al (2021) Letermovir Prophylaxis for Cytomegalovirus infection in allogeneic stem cell transplantation: a real-world experience. Front Oncol 11:740079. https:\/\/doi.org\/10.3389\/fonc.2021.740079","journal-title":"Front Oncol"},{"key":"4812_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/9781119857983.ch6","volume-title":"Deep learning for targeted treatments","author":"N Gaur","year":"2022","unstructured":"Gaur N, Dharwadkar R, Thomas J (2022) Personalized therapy using deep learning advances. In: Malviya R, Ghinea G, Danaraj RK, Balusamy B, Sundram S (eds) Deep learning for targeted treatments. John Wiley & Sons, Ltd, Beverly, pp 171\u2013197"},{"key":"4812_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1471-2334-14-151","volume":"20","author":"E Visser","year":"2014","unstructured":"Visser E, Milne D, Collacott I, McLernon D, Counsell C, Vickers M (2014) The epidemiology of infectious Mononucleosis in Northern Scotland: a decreasing incidence and winter peak. BMC Infect Dis 20:14:151. https:\/\/doi.org\/10.1186\/1471-2334-14-151","journal-title":"BMC Infect Dis"},{"key":"4812_CR20","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2147\/IDR.S180908","volume":"12","author":"G El Helou","year":"2019","unstructured":"El Helou G, Razonable RR (2019) Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. Infect Drug Resist 12:1481\u20131491. https:\/\/doi.org\/10.2147\/IDR.S180908","journal-title":"Infect Drug Resist"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04812-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04812-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T05:09:33Z","timestamp":1716268173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04812-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["4812"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04812-z","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was waived by the local Ethics Committee of Sapienza University of Rome in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}